State and Puerto Rico regulation of the drug supply chain is a patchwork - and we are here to help. This webinar will provide in-depth insight into all aspects of state regulation (licensing, disciplinary action notification, reporting, opioid tax and more) across several business models (CMO, virtual manufacturer, drug distributor, 503A/503B, pharmacy).
We'll cover topics including 2020 DEA updates to suspicious order monitoring, suspicious order state reporting requirements for distributors, opioid tax/fee calculations for distributors, and opioid treatment programs (OTPs) providing medication-assisted treatment (MAT). Further, we'll dive into content covering the NavigateSOM 2.0 addition of customer dashboards for enhanced diligence, and the NavigateSOM 2.0 addition of configurable reporting for enhanced capabilities.
In this webinar, we’ll cover topics including 503A vs 503B, USP changes, doing business in Puerto Rico, Licensing requirements, specifically PIC for a non-resident pharmacy & 503B, and accreditation requirements, with a focus on URAC vs VIPPS vs ACHC. We will also dive into content related to submitted questions, specifically regarding class of trade, the passage of the NNJ PBM law, and the Verified Pharmacy Program (VPP).
We'll cover topics including accreditation process changes, January 2017 and January 2019 applications, early effects of Optum Rx's VAWD requirement, and strategies for successfully obtaining VAWD accreditation. Further, we'll dive into content covering how VAWD affects pharmacies and manufacturers, updates on state by state VAWD recognition and requirements, and analysis of the facts and arguments in both lawsuits levied against Optum Rx.
In this webinar, we’ll cover topics including the changing value of the Title Model, recent changes to licensing requirements of CMOs and 3PLs, and doing business in Puerto Rico. We will also dive into content related to opioid taxes and fees and virtual manufacturer licensing.
In this webinar, we’ll cover topics including doing business in Puerto Rico, opioid taxes and fees, upcoming DEA regulation changes, accreditation requirements, specifically QAS vs VAWD, and vendor diligence. We will also dive into content related to sample distribution licensing and NJ PBM laws.
In this webinar, we’ll cover topics including sales strategy, specifically preparing for product launch, and marketing strategy, specifically, developing your value proposition. We will also dive into content related to portfolio strategy, specifically, organic growth and the fundamentals of product selection.
In this webinar, we’ll cover topics including the ‘patchwork’ quality of the pharmaceutical supply chain with regard to devices, requirements, and qualifications. We will also dive into content related to drug possession vs drug ownership.